Improving epilepsy control among children with cerebral palsy in rural Bangladesh: a prospective cohort-based study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 04 2022
Historique:
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

To define the prevalence and seizure subtypes among children with cerebral palsy (CP) in rural Bangladesh and explore barriers to optimum epilepsy control. Prospective cohort study. The study was conducted in Shahjadpur, a rural subdistrict of Bangladesh. Children (<18 years) with CP and epilepsy identified using the Bangladesh CP Register (BCPR) in the study site. Assessments were conducted in three focused epilepsy clinics overseen by a paediatric neurologist between December 2016 and January 2018, with intervening phone and video-conference follow-ups. Details of event type, frequency and medication compliance were collected. Antiepileptic drugs (AEDs) were prescribed based on seizure type, family income, comorbidity and medication availability. 23.4% (170/726) of the BCPR cohort had a clinical diagnosis of epilepsy of whom 166 were assessed. Following the focused epilepsy clinics, 62.0% (103/166) children were clinically determined to have ongoing epileptic seizures. 62.1% (64/103) had generalised onset tonic clonic seizures, 27.2% (28/103) had focal onset seizures with impaired awareness and 10.7% (11/103) had other seizure types. None of the children with prolonged seizures (31/103) had an emergency seizure management plan. Non-epileptic events were being pharmacologically treated as seizures in 18.1% (30/166) children. Financial constraints were the main reason for non-compliance on follow-up. Gaps in optimum epilepsy management in rural Bangladesh are amenable to improvement anchored with local healthcare workers. Training and clinical care focused on recognition of common seizure types, seizure mimics and rationalising use of available AEDs can be facilitated by better referral pathways and telehealth support.

Identifiants

pubmed: 35383059
pii: bmjopen-2021-052578
doi: 10.1136/bmjopen-2021-052578
pmc: PMC8984049
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e052578

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Neurol Sci. 2015 Nov 15;358(1-2):263-5
pubmed: 26371698
Child Care Health Dev. 2019 Jan;45(1):36-44
pubmed: 30304759
Hum Resour Health. 2011 Jan 22;9:3
pubmed: 21255446
Dev Med Child Neurol. 2019 Nov;61(11):1336-1343
pubmed: 31081134
J Child Neurol. 2003 Mar;18(3):174-9
pubmed: 12731642
N Engl J Med. 1998 Sep 17;339(12):792-8
pubmed: 9738086
BMC Neurol. 2015 Nov 25;15:245
pubmed: 26607561
Pediatr Neonatol. 2011 Feb;52(1):30-3
pubmed: 21385654
Dev Med Child Neurol. 2020 Dec;62(12):1414-1422
pubmed: 32686098
Pediatr Neurol. 1998 Jul;19(1):31-6
pubmed: 9682882
Dev Med Child Neurol. 2005 Aug;47(8):571-6
pubmed: 16108461
Expert Rev Neurother. 2015;15(7):733-40
pubmed: 26109227
Disabil Rehabil. 2021 Jan 04;:1-8
pubmed: 33397164
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Lancet Neurol. 2003 Jun;2(6):347-56
pubmed: 12849151
Seizure. 2019 Jan;64:54-58
pubmed: 30562653
Dev Med Child Neurol. 2019 May;61(5):601-609
pubmed: 30394528
Child Care Health Dev. 2017 Nov;43(6):861-868
pubmed: 28744889
Lancet. 2013 Sep 21;382(9897):1060-9
pubmed: 23697823
Dev Med Child Neurol. 1990 Mar;32(3):191-202
pubmed: 2179001
Dev Med Child Neurol. 1990 Aug;32(8):661-8
pubmed: 2210081

Auteurs

Tasneem Karim (T)

Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
CSF Global, Dhaka, Bangladesh.
Asian Institute of Disability and Development, University of South Asia, Dhaka, Bangladesh.

Manik Chandra Das (MC)

CSF Global, Dhaka, Bangladesh.
Asian Institute of Disability and Development, University of South Asia, Dhaka, Bangladesh.

Mohammad Muhit (M)

CSF Global, Dhaka, Bangladesh.
Asian Institute of Disability and Development, University of South Asia, Dhaka, Bangladesh.

Nadia Badawi (N)

Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Sydney Medical School, Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, Australia.

Gulam Khandaker (G)

Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
CSF Global, Dhaka, Bangladesh.
Asian Institute of Disability and Development, University of South Asia, Dhaka, Bangladesh.
Dept of Public Health, Central Queensland Hospital and Health Service, Rockhampton, Queensland, Australia.

Shekeeb S Mohammad (SS)

Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia shekeeb.mohammad@sydney.edu.au.
TY Nelson Dept of Neurology and Neurosurgery, The Children's Hospital at Westmead, Sydney Children's Hospitals Network, Westmead, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH